logo

ALHC

Alignment Healthcare·NASDAQ
--
--(--)
--
--(--)
4.32 / 10
Netural

ALHC's fundamental score of 4.3/10 reflects modest health: strengths in cash-flow and earnings growth (Cash-MV: 0.4695, Net cash flow/share YoY: 319.3) are offset by a negative Net income-Revenue (-3.463) and middling Revenue-MV (0.924). Historical back-tests show low one-month returns (0.59% to 2.78%) across key factors, suggesting limited immediate catalysts. Overall, the company appears defensive but not compelling.

Fundamental(4.32)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value0.92
Score1/3
Weight2.07%
1M Return0.59%
Net cash flow from operating activities per share (YoY growth rate %)
Value319.30
Score3/3
Weight19.96%
1M Return5.16%
Net income-Revenue
Value-3.46
Score1/3
Weight8.16%
1M Return2.53%
Basic earnings per share (YoY growth rate %)
Value109.80
Score2/3
Weight9.66%
1M Return2.78%
Total profit (YoY growth rate %)
Value113.69
Score2/3
Weight7.34%
1M Return2.01%
Net cash flow from operating activities (YoY growth rate %)
Value337.67
Score3/3
Weight20.42%
1M Return5.21%
Diluted earnings per share (YoY growth rate %)
Value109.80
Score2/3
Weight8.20%
1M Return2.41%
Asset-MV
Value-0.50
Score1/3
Weight6.20%
1M Return1.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value110.61
Score2/3
Weight9.58%
1M Return2.61%
Cash-MV
Value0.47
Score2/3
Weight8.41%
1M Return2.59%
Is ALHC fundamentally strong?
  • ALHC scores 4.32/10 on fundamentals and holds a Fair valuation at present. Backed by its 7.82% ROE, -0.58% net margin, -209.14 P/E ratio, 26.89 P/B ratio, and 85.53% earnings growth, these metrics solidify its Netural investment rating.